Coagulatory defects in type-1 and type-2 diabetes

Amelie Isabelle Sylvie Sobczak, Alan J. Stewart

Research output: Contribution to journalReview articlepeer-review

50 Citations (Scopus)
3 Downloads (Pure)


Diabetes (both type-1 and type-2) affects millions of individuals worldwide. A major cause of death for individuals with diabetes is cardiovascular diseases, in part since both types of diabetes lead to physiological changes that affect haemostasis. Those changes include altered concentrations of coagulatory proteins, hyper-activation of platelets, changes in metal ion homeostasis, alterations in lipid metabolism (leading to lipotoxicity in the heart and atherosclerosis), the presence of pro-coagulatory microparticles and endothelial dysfunction. In this review, we explore the different mechanisms by which diabetes leads to an increased risk of developing coagulatory disorders and how this differs between type-1 and type-2 diabetes.
Original languageEnglish
Article number6345
Number of pages28
JournalInternational Journal of Molecular Sciences
Issue number24
Publication statusPublished - 16 Dec 2019


  • Atherosclerosis
  • Endothelial dysfunction
  • Magnesium
  • Metal ions
  • Microparticles
  • Platelets
  • Thrombosis
  • Zinc


Dive into the research topics of 'Coagulatory defects in type-1 and type-2 diabetes'. Together they form a unique fingerprint.

Cite this